New ADHD Drugs, Same Old Problems

A new version of an old version of Ritalin isn’t exactly a breakthrough.

Photo by Christina Victoria Craft on Unsplash

The FDA approved two new ADHD drugs this year, and they’re being marketed as shiny new medical advances. It sounds exciting, but are these drugs really new and different?

Azstaryz is a stimulant developed by KemPharm, whose CEO called it “the first truly differentiated ADHD medication in years”, and Qelbree

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Jesse Meadows

writer + digital artist doing critical adhd studies + re-politicizing mental health | they/them